Follow-Up for Stage III Melanoma
|
Type of Followup |
Description of Followup |
|---|---|
|
Physical x-rays, CT scans (trunk,pelvis, head) |
Year 1: every 3 months Year 2 : every 4 months Years 3-5: at least every 6 months Annually after 5 years |
|
Testing for LDH (Serum Lactate Dehydrogenase) |
For all patients at same time as physical exam |
All patients with Stage III melanoma should have a physical examination, including LDH testing, skin examination, chest x-rays, CT scans of trunk, pelvis and head every 3 months for the first year, every 4 months for the second year, every 6 months for years 3-5, and annually after 5 years.
With treatment, Stage III melanoma is considered intermediate- to high-risk for local recurrence or distant metastasis. Therefore, early detection of melanoma through skin self- examination and medical examination continues to be of utmost importance.
Large-scale studies have shown the following probabilities of disease-free survival. Keep in mind that the statistics shown for survival are averages; everyone's cancer and survival rate is based on many factors and determined on an individual basis.
Survival
| 5 years after treatment [1] | 10 years after treatment [1] |
| Stage IIIA 57% -73% | Stage IIIA: 48% -51% |
| Stage IIIB 50%-68% |
Stage IIIB: 44% - 60%
|
| Stage IIIC 27% - 52% |
Stage IIIC: 22% - 37%
|
For more on what to do if Melanoma Recurs click here
Reference: [1]American Cancer Society; [2]Balch CM, Buzaid AC, Soong S-J, et al. Final version of the American Joint Committee on Cancer staging system for cutaneous melanoma. J Clin Oncol. 2001;19(16):3635-3648.

Important links